drugset / Trial / NCT01000987

Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders

NCT01000987

Phase 2 Completed 44 enrolled Yale University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is the examine the effect of varenicline on cognition to a high dose (0.08 g/dL) of alcohol (vs. placebo alcohol) over the ascending and descending limb of the blood alcohol curve.

Timeline

Start
2009-10
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg
Subject Varenicline Small molecule 2 mg

Indications

No indication recorded.